+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of a congenital pseudarthrosis of the tibia by recombinant bone morphogenetic protein-7



Treatment of a congenital pseudarthrosis of the tibia by recombinant bone morphogenetic protein-7



Calcified Tissue International 72(4): 346




(PDF emailed within 1 workday: $29.90)

Accession: 035980670

Download citation: RISBibTeXText


Related references

Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7). A report of five cases. Journal of Bone and Joint Surgery. American Volume 88(3): 627-633, 2006

Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia. Journal of Children's Orthopaedics 4(6): 507-517, 2011

Combined treatment of congenital pseudarthrosis of the tibia, including recombinant human bone morphogenetic protein-2: a case series. Journal of Bone and Joint Surgery. British Volume 93(5): 695-699, 2011

Bone morphogenetic protein 7 in the treatment of congenital pseudarthrosis of the tibia. Journal of Bone and Joint Surgery. British Volume 88(1): 116-118, 2005

Congenital pseudarthrosis of the tibia Treatment with a bone morphogenetic protein. Calcified Tissue International 70(4): 256, 2002

Treatment of a congenital pseudarthrosis of the tibia by osteogenic protein-1 (bone morphogenetic protein-7): a case report. Journal of Pediatric Orthopedics. Part B 15(3): 220-221, 2006

Masquelet's procedure and bone morphogenetic protein in congenital pseudarthrosis of the tibia in children: a case series and meta-analysis. Journal of Children's Orthopaedics 6(4): 297-306, 2013

Burnei's procedure in the treatment of long bone pseudarthrosis in patients having osteogenesis imperfecta or congenital pseudarthrosis of tibia - preliminary report. Journal of Medicine and Life 5(2): 215-221, 2014

Effectiveness of recombinant human bone morphogenetic protein-7 in the management of congenital pseudoarthrosis of the tibia: a randomised controlled trial. International Orthopaedics 38(9): 1987-1992, 2015

Treatment of congenital pseudarthrosis of the tibia with free vascularized bone graft. Clinical Orthopaedics and Related Research 1982(166): 34-44, 1982

Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation. Spine Journal 11(6): 568-576, 2011

Successful use of intramedullar nail and bone transplant in the treatment of a congenital pseudarthrosis of the tibia. Zeitschrift für Orthopadie und ihre Grenzgebiete 80(1): 93-97, 1950

On the use and osteogenic role of maternal bone homografts in the treatment of congenital pseudarthrosis of the tibia in children. Chirurgia Narzadow Ruchu i Ortopedia Polska 27: 43-47, 1962

The effects of recombinant human bone morphogenetic protein-2, recombinant human bone morphogenetic protein-12, and adenoviral bone morphogenetic protein-12 on matrix synthesis in human annulus fibrosis and nucleus pulposus cells. Spine Journal 8(3): 449-456, 2008

Biological basis for the use of autologous bone marrow stromal cells in the treatment of congenital pseudarthrosis of the tibia. Bone 46(3): 780-788, 2010